These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30321524)

  • 1. Utility of estimated glomerular filtration rate using cystatin C and its interpretation in patients with rheumatoid arthritis under glucocorticoid therapy.
    Nozawa Y; Sato H; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Kazama JJ; Suzuki Y; Nakano M; Narita I
    Clin Chim Acta; 2018 Dec; 487():299-305. PubMed ID: 30321524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Japanese glomerular filtration rate equation based on standardized serum cystatin C in potential kidney donors.
    Horio M; Yasuda Y; Kaimori J; Ichimaru N; Kakuta Y; Isaka Y; Matsuo S; Takahara S
    Transplant Proc; 2014; 46(2):314-7. PubMed ID: 24655951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of using inulin clearance and cystatin C for determining glomerular filtration rate in HIV-1-infected individuals treated with dolutegravir.
    Yukawa S; Watanabe D; Uehira T; Shirasaka T
    J Infect Chemother; 2018 Mar; 24(3):199-205. PubMed ID: 29150412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.
    Shibata K; Yasuda Y; Kobayashi R; Ando Y; Shimokata T; Kamiya H; Hayashi M; Maruyama S; Matsuo S; Nakao M; Tsuchiya T; Teramachi H
    Clin Exp Nephrol; 2015 Dec; 19(6):1107-13. PubMed ID: 25894220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
    Ichioka D; Kawai K; Tanaka K; Ishitsuka R; Yoshino T; Kimura T; Kandori S; Kawahara T; Kojima T; Usui J; Yamagata K; Miyazaki J; Nishiyama H
    Clin Exp Nephrol; 2018 Jun; 22(3):727-734. PubMed ID: 28948387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors Resulting Correlation and Differences in Renal Function Evaluation Index Using the Serum Cystatin C and Creatinine as Measured by an Enzymatic Method].
    Takahashi M; Takayama S; Suga H; Kadomura S; Kojima M; Iwao K; Takeda K; Sato H; Kobayashi M; Saitoh H
    Yakugaku Zasshi; 2020; 140(1):81-90. PubMed ID: 31902889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dose and type of corticosteroids on the divergence between estimated glomerular filtration rates derived from cystatin C and creatinine.
    Tsushita H; Tanaka R; Suzuki Y; Sato Y; Itoh H
    J Clin Pharm Ther; 2020 Dec; 45(6):1390-1397. PubMed ID: 32705707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Estimated Glomerular Filtration Rate Based on Cystatin C and Grip Strength in Community-Dwelling Japanese Older Adults.
    Kabasawa K; Nakamura K; Ito Y; Tanaka J; Narita I
    J Gerontol A Biol Sci Med Sci; 2021 Aug; 76(9):1653-1660. PubMed ID: 32971533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Importance of GFR-Estimating Equations (eGFRcreat and eGFRcys)].
    Horio M
    Rinsho Byori; 2015 Feb; 63(2):259-64. PubMed ID: 26529980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of differences in cystatin C and creatinine-based estimated glomerular filtration rate in community-dwelling older adults: a cross-sectional study.
    Legrand H; Werner K; Christensson A; Pihlsgård M; Elmståhl S
    BMC Nephrol; 2017 Dec; 18(1):350. PubMed ID: 29202804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C-based estimated glomerular filtration rate and periodontitis.
    Iwasaki M; Taylor GW; Sato M; Nakamura K; Yoshihara A; Miyazaki H
    Gerodontology; 2016 Sep; 33(3):328-34. PubMed ID: 25294234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for shrunken pore syndrome in children.
    den Bakker E; Gemke RJ; van Wijk JA; Hubeek I; Stoffel-Wagner B; Bökenkamp A
    Scand J Clin Lab Invest; 2020 Feb; 80(1):32-38. PubMed ID: 31755786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.
    Zhao JB; Liu Y; Wu DX; Chen JY; Duan CY; Chen SQ; Tan N
    Angiology; 2017 Mar; 68(3):207-215. PubMed ID: 27166381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging.
    Peralta CA; Lee A; Odden MC; Lopez L; Zeki Al Hazzouri A; Neuhaus J; Haan MN
    J Am Geriatr Soc; 2013 Jan; 61(1):90-5. PubMed ID: 23252993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer.
    Hanna PE; Ouyang T; Tahir I; Katz-Agranov N; Wang Q; Mantz L; Strohbehn I; Moreno D; Harden D; Dinulos JE; Cosar D; Seethapathy H; Gainor JF; Shah SJ; Gupta S; Leaf DE; Fintelmann FJ; Sise ME
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1187-1198. PubMed ID: 38646842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C for kidney function assessment in patients with facioscapulohumeral muscular dystrophy.
    Mondesert E; Bargnoux AS; Portet F; Laoudj-Chenivesse D; Arbogast S; Badiou S; Brun JF; Kuster N; de Mauverger ER; Cristol JP
    Clin Chim Acta; 2023 Apr; 544():117328. PubMed ID: 37031784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C and Muscle Mass in Patients With Heart Failure.
    Ivey-Miranda JB; Inker LA; Griffin M; Rao V; Maulion C; Turner JM; Wilson FP; Tang WHW; Levey AS; Testani JM
    J Card Fail; 2021 Jan; 27(1):48-56. PubMed ID: 32750487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients.
    Targońska-Stepniak B; Majdan M
    Scand J Rheumatol; 2011; 40(5):341-6. PubMed ID: 21619490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.